Chairman Kobayashi (小林) of Meiji Seika Pharma positioned the Kyoso organization as a platform operator for the stable supply of generic drugs and called on companies to participate in product consolidation. Its role as an initiative aimed at ensuring a stable supply of generic drugs was emphasized.
Chairman Kobayashi (小林) of Meiji Seika Pharma expressed the view that the Kyoso organization should serve as a platform operator for the stable supply of generic drugs. Although the text does not provide details of its specific business model or operating structure, the organization was presented as playing a central role in ensuring stable supply.
The Kyoso organization has set the realization of product consolidation as a goal and is said to have called on companies to participate in consolidating the relevant products. The stated objectives of consolidation apparently include securing supply stability and market soundness, but the text does not specify the scope or timing of the consolidation.
The text does not address future developments, specific participation requirements, or the responses of other companies. Readers will need to monitor progress on product consolidation and the Kyoso organization’s activities.